查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1803509

非微生物生物刺激素市场按产品类型、产地、作物类型、形态、应用方法、最终用户和分销管道划分 - 全球预测，2025-2030 年

Non-microbial Biostimulants Market by Product Type, Source, Crop Type, Form, Application Method, End User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

非微生物生物刺激素市场预计在 2024 年达到 17.5 亿美元，在 2025 年成长至 19.8 亿美元，在 2030 年达到 37.2 亿美元，复合年增长率为 13.33%。

主要市场统计数据
基准年2024年 17.5亿美元
预计2025年 19.8亿美元
预测年份 2030 37.2亿美元
复合年增长率（%） 13.33%

全面介绍非微生物生物刺激素及其在促进现代农业系统永续作物生产中的作用

随着种植者、配方师和经销商寻求能够提高作物抗逆性、养分利用效率和植物整体性能的工具，而非仅仅依赖传统农药，非微生物生物刺激素领域正受到越来越多的关注。萃取、分馏和製剂科学领域的创新正在拓宽农学家可用的活性成分范围，而不断发展的农艺实践和永续性重点也正在推动其在各种种植系统中的应用。同时，供应链动态和监管压力正在重塑相关人员采购投入和设计应用方案的方式。

科学检验、买家成熟度与通路创新如何融合，重新定义整个生物刺激素领域的竞争优势

由于监管环境、种植者期望和技术能力的变化，非微生物生物刺激素正从一种小众补充剂演变为作物综合管理的核心组成部分。近几季，其功效宣传受到越来越严格的审查，促使供应商透过可重复的田间试验和更先进的分析表征来证实其功效。这种对证据的重视增强了产品的差异化，那些展现出持续生理功效的产品获得了优先的试验和分销支持。

近期关税对美国采购、配方策略和供应链弹性的业务和商业影响

美国近期的关税措施导致非微生物生物刺激素供应链的复杂程度不断提升，影响了原料采购、配方成本和物流规划。由于许多活性成分和原料来自全球各地的供应商，尤其是在拥有专业提取能力的地区，进口关税的变化迫使配方师重新评估筹资策略。这种重新评估可能包括：将某些原料近岸外包，寻找拥有重迭化学品的合格替代供应商，以及增加缓衝库存以对冲波动性。

精准细分洞察揭示产品类型、产地、作物类型、形式、应用和通路如何决定技术优先顺序和商业性成功

細項分析揭示了产品结构、来源特征、作物最终用途、物理形态、应用形式、最终用户概况和通路动态如何影响产品开发优先顺序和商业策略。在考虑产品类型时，包括胺基酸和胜肽、腐殖质、植物抽取物、蛋白质水解物和海藻萃取物在内的产品组合必须平衡功效、一致性和成本。在胺基酸和胜肽中，螯合氨基溶液和胜肽提供不同的功能特性；富里酸和腐殖酸钾在腐殖质中提供差异化的途径；植物抽取物和植物激素萃取物在植物抽取物中提供不同的作用方式。无机来源和有机来源的选择会影响配方选择、监管途径和种植者偏好，进而影响作物产品定位。

采用模式和营运考量需要协调美洲、欧洲、中东和非洲地区以及亚太地区的产品、监管和通路策略

各地区在应用驱动因素和商业动态的差异凸显了美洲、欧洲、中东和非洲以及亚太地区制定客製化策略的必要性。在美洲，种植者通常优先考虑能够与大规模机械化作业无缝衔接，并能显着提高养分效率和缓解压力的解决方案。分销网络正在多元化，涵盖强大的批发和零售管道，数位化采购正在加速商业农产品对数位化的采用。该地区也体现出一种现实的结合：高价值园艺作物的早期采用，以及对具有明显农艺效益回报的大面积作物日益增长的兴趣。

产业领导者的策略剧本强调证据、供应链弹性、数位化支持和伙伴关係主导的商业规模

非微生物生物刺激素领域的主要企业正聚焦于几项策略重点，这些重点使高绩效企业在众多竞争对手中脱颖而出。其中最主要的是投资于获取强而有力的证据，利用综合测试网络和独立检验研究来证明在代表性农艺条件下的生理功效。此类科学投资，加上清晰的农艺指导和教育计划，增强了经销商和种植者对产品性能的信心。

企业现在可以采取切实可行的措施来增强供应弹性、检验跨地域绩效并优化产品组合和通路经济效益

行业领导者可以立即采取措施，将技术投资与商业性执行和营运韧性相结合，从而巩固其市场地位。优先开展跨地区、作物类型的严格田间检验项目，以建立坚实的依证，支持差异化宣传，并为农艺指导提供参考。在验证的同时，重新评估您的供应链，并专注于供应商多元化、品质保证控制和合约条款，以降低贸易政策波动带来的机会。这种双重关注既能保护产品完整性，又能支援灵活的筹资策略。

综合混合方法研究途径，结合初步测试、相关人员访谈、技术文件审查和供应链检验，以获得可行的见解

本研究整合了主要农艺试验数据、供应商和经销商访谈、产品技术文件以及专注于製剂科学和贸易动态的二手文献。主要研究包括与农艺师、製剂化学家、采购主管和通路合作伙伴进行结构化讨论，以了解业务现状以及对近期政策变化的策略回应。试验评估强调在代表性环境条件下进行重复试验，并包括定性农艺观察和定量生理指标（如有）。

策略要务整合，将科学检验、采购敏捷性和客製化商业模式与持久的竞争成果结合

最后，非微生物生物刺激素领域正处于技术创新和商业性成熟的十字路口。随着循证检验成为市场准入的必要条件，那些投资于严格测试、灵活采购和针对特定管道的价值提案的公司将有望获得竞争优势。贸易政策的发展和区域结构差异将要求企业制定适应性策略，将采购弹性与有针对性的产品设计相结合。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

  • 奈米胶囊腐植酸和富里酸配方的开发，用于作物测试中的控制释放
  • 增加海藻萃取物与微量营养素的结合使用，以提高作物的抗旱能力
  • 引入基于无人机和无人驾驶飞机的叶面喷布系统，以实现精准的非微生物生物刺激剂施用
  • 美国和欧盟加强监管协调，简化植物来源生物刺激素註册流程
  • 将非微生物生物刺激剂整合到种子披衣中可促进根系早期发育和均匀出苗
  • 利用高通量表型分析量化非生物胁迫条件下生物刺激素治疗的功效

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

8. 非微生物生物刺激素市场（依产品类型）

  • 胺基酸和胜肽
    • 螯合氨基溶液
    • 胜肽
  • 腐植质
    • 富里酸
    • 腐植酸钾
  • 植物萃取物
    • 植物萃取物
    • 植物激素萃取物
  • 蛋白质水解物
  • 海藻萃取物

9. 非微生物生物刺激素市场（依来源）

  • 无机
  • 有机的

10. 非微生物生物刺激素市场（依作物类型）

  • 田间作物
    • 粮食
    • 油籽
    • 豆子
  • 水果和蔬菜
    • 莓果
    • 莴苣
    • 番茄
  • 观赏植物
    • 芙蓉
    • 兰花
    • 玫瑰
    • 郁金香
  • 草地
    • 狗狗牙根草
    • 肯塔基蓝草

11. 非微生物生物刺激素市场（依形态）

  • 液体
    • 集中
    • RTU
  • 粉末
    • 颗粒状
    • 可溶性粉剂

12. 非微生物生物刺激素市场（依应用）

  • 叶面喷布
    • 无人机应用
    • 手动应用
  • 种子处理
    • 涂层
    • 启动
  • 土壤处理
    • 滴灌
    • 施肥灌溉

13. 非微生物生物刺激素市场（依最终用户）

  • 商业用户
  • 个人用户

14. 非微生物生物刺激素市场（按分销管道）

  • 离线
  • 在线的
    • 公司网站
    • 第三方市场

15. 美洲非微生物生物刺激素市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

16. 欧洲、中东和非洲非微生物生物刺激素市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

17. 亚太地区非微生物生物刺激素市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十八章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • BASF SE
    • Syngenta AG
    • Agricen
    • Agrinos Inc.
    • AgroLiquid
    • Arysta LifeScience Corporation
    • Bio Huma Netics, Inc.
    • Bioiberica SA
    • Biolchim SpA
    • Biostadt India Limited
    • Corteva, Inc.
    • FMC Corporation
    • Haifa Group
    • Helena Agri-Enterprises LLC
    • Hello Nature Worldwide
    • Isagro SpA
    • Koppert Biological Systems
    • L.Gobbi Srl
    • Lallemand Inc.
    • Novozymes A/S
    • Rovensa Next
    • Seipasa
    • UPL Limited

第十九章 研究人工智慧

第20章 研究统计

第21章 研究联络人

第22章 研究报导

第23章 附录

Product Code: MRR-F14BA1B34144

The Non-microbial Biostimulants Market was valued at USD 1.75 billion in 2024 and is projected to grow to USD 1.98 billion in 2025, with a CAGR of 13.33%, reaching USD 3.72 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 1.75 billion
Estimated Year [2025] USD 1.98 billion
Forecast Year [2030] USD 3.72 billion
CAGR (%) 13.33%

A comprehensive orientation to non-microbial biostimulants and their role in advancing sustainable crop performance across modern agricultural systems

The non-microbial biostimulants sector is undergoing a period of heightened attention as growers, formulators, and distributors seek tools that improve crop resilience, nutrient use efficiency, and overall plant performance without relying solely on traditional agrochemicals. Innovations in extraction, fractionation, and formulation science have broadened the suite of active ingredients available to agronomists, while evolving agronomic practices and sustainability priorities have increased adoption across diverse cropping systems. Concurrently, supply chain dynamics and regulatory pressures are reshaping how stakeholders source inputs and design application programs.

This introduction positions the reader to understand the interplay between product innovation, channel transformation, and regulatory developments. It highlights the importance of integrating technical efficacy with commercial viability, and it frames subsequent sections that explore structural shifts, tariff impacts, segmentation-derived insights, regional differentiators, corporate strategies, and practical recommendations. By focusing on the intersection of science, supply chains, and grower economics, the study equips stakeholders to make informed choices about product portfolios, partnerships, and go-to-market models.

How scientific validation, buyer sophistication, and channel innovation are converging to redefine competitive advantage across the biostimulant landscape

The landscape of non-microbial biostimulants is shifting from a niche adjunct to a core component of integrated crop management, driven by changes in regulatory frameworks, grower expectations, and technological capability. Over recent seasons, performance claims have been scrutinized more rigorously, prompting suppliers to substantiate benefits through replicated field trials and enhanced analytical characterization. This emphasis on evidence has elevated product differentiation, with those that demonstrate consistent physiological benefits winning preferential trial placements and distribution support.

Simultaneously, buyer behavior is evolving. Commercial users and individual growers increasingly demand ease of use, compatibility with existing nutrient programs, and transparent sourcing. This demand has incentivized suppliers to prioritize formulation stability, label clarity, and application flexibility, including offerings suitable for foliar, seed, or soil treatments across diverse crop types. The shift toward digital procurement channels and direct-to-grower models has introduced new competitive dynamics for traditional distributors and retailers. In parallel, partnerships between ingredient producers and formulators have accelerated, enabling faster route-to-market for novel extracts and concentrated solutions. These alliances often center on co-development, intellectual property sharing, and aligned go-to-market investments.

As the industry professionalizes, sustainability narratives are being reframed to emphasize quantifiable agronomic benefits rather than generic environmental claims. That reframing supports adoption in crops where return on investment is scrutinized closely and expands the relevance of biostimulants beyond premium horticulture into broader field crop applications. Taken together, these transformative shifts signal a maturing category where scientific rigor, commercial execution, and supply chain resilience determine competitive advantage.

The layered operational and commercial consequences of recent tariff measures on sourcing, formulation strategy, and supply chain resilience in the United States

Recent tariff actions implemented in the United States have introduced a layer of complexity across the non-microbial biostimulant supply chain, affecting feedstock sourcing, formulation costs, and logistics planning. Because many active ingredients and raw materials originate from diverse global suppliers, particularly in regions with specialized extraction capabilities, changes in import duties have forced formulators to reassess procurement strategies. This reassessment has included nearshoring certain inputs, qualifying alternate suppliers with overlapping chemistries, and increasing buffer inventories to hedge against volatility.

The cumulative effect has been more than a simple price adjustment; it has reshaped commercial relationships and product development timelines. Suppliers with vertically integrated supply chains or diversified sourcing have been better positioned to absorb tariff-related cost pressures while maintaining stable customer offerings. Conversely, smaller formulators and niche suppliers that relied on single-source imports have faced longer lead times and higher landed costs, prompting some to reevaluate their product portfolios or to accelerate reformulation efforts that use tariff-exempt or domestically sourced alternatives.

Operationally, logistics and trade compliance teams have taken on greater prominence within commercial functions, collaborating more closely with product managers to assess duty classification, origin documentation, and cost pass-through strategies. In many cases, companies have adopted a segmented approach that prioritizes continuity for high-value, performance-differentiated formulations while seeking cost-effective substitutes for more commoditized blends. From a go-to-market standpoint, channel partners are negotiating revised pricing models and promotional frameworks to reflect altered cost structures, and procurement teams are emphasizing multi-source qualification and long-lead contracting to mitigate future shocks. These adjustments illustrate how trade policy reverberates through product design, commercial negotiation, and operational planning, reinforcing the need for resilient sourcing strategies and flexible formulation roadmaps.

Precision segmentation insights revealing how product types, sources, crop demands, forms, applications, and channels determine technical priorities and commercial success

Segmentation analysis reveals how product architecture, source characteristics, crop end-use, physical form, application modality, end-user profile, and channel dynamics collectively shape product development priorities and commercial strategies. When considering product type, portfolios that include amino acids and peptides, humic substances, plant extracts, protein hydrolysates, and seaweed extracts must balance efficacy, consistency, and cost; within amino acids and peptides, chelated amino solutions and peptides provide distinct functional profiles, while fulvic acid and potassium humate represent differentiated pathways within humic substances, and botanical extracts and plant hormone extracts offer varying modes of action within plant extracts. Source selection between inorganic and organic options informs formulation choices, regulatory pathways, and grower preferences, and influences how products are positioned across crops.

Crop type segmentation further drives technical and commercial decisions, with formulations tailored to the physiological demands of field crops, fruits and vegetables, ornamentals, and turf grass. Field crops such as cereals, oilseeds, and pulses require scalability and compatibility with mechanized application, whereas fruits and vegetables like berries, lettuce, and tomatoes often demand targeted solutions that support yield consistency and post-harvest quality. Ornamentals, including hibiscus, orchids, roses, and tulips, prioritize aesthetic attributes and precise nutrient modulation, and turf grass types such as bermudagrass and kentucky bluegrass focus on stress tolerance and rapid recovery. Form considerations-liquid versus powder-affect shelf life, ease of handling, and application flexibility; liquids that are formulated as concentrate or ready-to-use solutions offer different value propositions compared to powders available as granular or soluble powder formats.

Application method segmentation-foliar spray, seed treatment, and soil treatment-shapes both formulation science and go-to-market mechanics. Foliar products that accommodate drone application or manual application must harmonize droplet stability and coverage, while seed treatments that utilize coating or priming technologies intersect with seed supply chains and treatment infrastructure. Soil treatments delivered via drip irrigation or fertigation require solubility and compatibility with irrigation systems. End-user differentiation between commercial users and individual users affects packaging sizes, technical support expectations, and distribution preferences. Distribution channel segmentation between offline and online channels, with online trade split between company websites and third-party marketplaces, drives how brands allocate marketing investments, control product narratives, and manage pricing consistency across touchpoints. By integrating these segmentation dimensions, companies can prioritize formulation investments, channel strategies, and customer support models that align with the specific needs of target cohorts.

Regional adoption patterns and operational considerations that require tailored product, regulatory, and channel strategies across the Americas, EMEA, and Asia-Pacific

Regional differentiation in adoption drivers and commercial dynamics underscores the need for tailored strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, growers often prioritize solutions that integrate seamlessly with large-scale mechanized operations and that offer demonstrable improvements in nutrient efficiency and stress mitigation; distribution networks are diversified and include strong wholesale and retail channels, and digital purchasing is accelerating adoption among commercial agribusinesses. This region also reflects a pragmatic mix of early uptake for high-value horticultural applications and scaling interest in broadacre crops where return on agronomic performance is clear.

In Europe, Middle East & Africa, regulatory scrutiny around inputs and environmental outcomes has prompted suppliers to emphasize compliance documentation and transparent ingredient sourcing. Grower expectations in this region often center on sustainable credentials and traceability, which shapes labeling and communication strategies. Meanwhile, localized climatic stressors and crop mixes necessitate region-specific formulations and application recommendations, and partnerships with local agronomy providers are essential for adoption.

Asia-Pacific exhibits a complex mosaic of smallholder-dominated landscapes and rapidly modernizing commercial agriculture. In many countries, intensive cropping systems and limited arable land encourage adoption of products that enhance resource efficiency and resilience. Distribution varies considerably, with some markets driven by modern trade and e-commerce while others rely on traditional agro-dealers. Supply chain considerations, including proximity to extraction and processing facilities for seaweed and plant extracts, influence cost structures and product availability. Across regions, companies that adapt technical claims, packaging sizes, and channel engagement models to local agronomic realities and purchasing behaviors are best positioned to convert interest into sustained use.

Strategic playbook of industry leaders emphasizing evidence, supply chain resilience, digital enablement, and partnership-driven commercial scale

Leading companies in the non-microbial biostimulant space are converging on several strategic priorities that distinguish high-performing organizations from the broader competitive set. Foremost is an investment in robust evidence generation, where integrated trial networks and independent validation studies are used to substantiate physiological effects under representative agronomic conditions. Firms pairing these scientific investments with clear agronomic guidance and educational programs strengthen distributor and grower confidence in product performance.

Supply chain differentiation is another hallmark of successful players. Companies that secure diversified feedstock pools, maintain flexible formulation platforms, and invest in formulation technologies that improve stability and ease of application create commercial advantages. These capabilities are often complemented by closer integration with distribution partners, where shared demand planning and co-marketing initiatives align incentives and reduce churn. Additionally, digital tools that deliver precision dosing recommendations, application timing alerts, and performance tracking have become key differentiators, supporting repeat purchase and enabling outcome-based conversations with customers.

On the commercial front, leading organizations deploy tiered portfolio strategies that balance high-margin, performance-differentiated products with broader-use, price-sensitive offerings. This approach allows for targeted investment in innovation while maintaining broad market reach. Finally, companies that pursue strategic partnerships-whether through co-development agreements with raw-material specialists or distribution alliances with regional channel leaders-amplify scale and accelerate market penetration without proportionate increases in fixed costs. These combined capabilities shape an organizational playbook that couples science, supply resilience, and commercial execution.

Actionable steps companies should implement now to fortify supply resilience, validate performance across geographies, and optimize portfolio and channel economics

Industry leaders can take immediate steps to strengthen market position by aligning technical investments with commercial execution and operational resilience. Prioritize rigorous field validation programs that span geographies and crop types to create a robust evidence base that supports differentiated claims and informs agronomic guidance. Parallel to validation, reevaluate supply chains with an emphasis on supplier diversification, quality assurance controls, and contractual terms that reduce exposure to trade policy volatility. This dual focus will protect product integrity while enabling adaptive sourcing strategies.

Commercially, refine portfolio architecture to explicitly link product tiers to customer segments and channel economics. Invest in packaging and formulation formats that match end-user preferences, from concentrated liquids for large-scale commercial operations to convenient ready-to-use options for individual users. Enhance digital engagement by deploying decision-support tools and performance dashboards that increase perceived value and foster loyalty. Operationally, strengthen cross-functional collaboration among R&D, procurement, and sales teams to accelerate reformulation cycles when feedstock constraints emerge and to streamline product introductions.

Finally, build strategic partnerships that extend capabilities without commensurate fixed-cost increases. Co-development agreements with extraction specialists, joint trials with leading growers, and distribution alignments in key regions will expand reach and credibility. Implementing these recommendations will help companies translate scientific promise into durable commercial advantage while mitigating external risks.

An integrated mixed-methods research approach combining primary trials, stakeholder interviews, technical dossier review, and supply chain verification to generate actionable insights

This study synthesizes primary agronomic trial data, supplier and distributor interviews, product technical dossiers, and secondary literature focused on formulation science and trade dynamics. Primary engagement included structured discussions with agronomists, formulation chemists, procurement leads, and channel partners to capture operational realities and strategic responses to recent policy shifts. Trial evaluations emphasized replicated trials under representative environmental conditions and included both qualitative agronomic observations and quantitative physiological markers when available.

Secondary sources were reviewed to contextualize ingredient sourcing trends, regulatory developments, and channel evolution. Trade and logistics inputs were corroborated through discussions with supply chain specialists and customs compliance professionals to ensure that tariff implications were reflected in operational decision-making. Throughout the research process, findings were triangulated across data streams to ensure consistency and to identify gaps requiring further validation. The methodology deliberately emphasized actionable insights and cross-functional relevance to support commercial decision-makers and technical leads alike.

Synthesis of strategic imperatives that tie scientific validation, sourcing agility, and tailored commercial models to durable competitive outcomes

In closing, the non-microbial biostimulant domain stands at the intersection of technical innovation and commercial maturation. As evidence-based validation becomes a market entry requirement, companies that invest in rigorous trials, resilient sourcing, and channel-specific value propositions will secure competitive advantage. Trade policy developments and regional structural differences necessitate adaptive strategies that integrate procurement agility with targeted product design.

The cumulative themes of scientific rigor, supply chain resilience, and differentiated commercial execution point to a pragmatic road map: validate claims in the contexts that matter to end users, structure portfolios to match operational realities across crop types and regions, and partner strategically to scale without losing technical focus. Executives and functional leaders that operationalize these priorities will be better positioned to convert biostimulant potential into tangible agronomic and commercial outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Development of nano-encapsulated humic and fulvic acid formulations for controlled release in crop trials
  • 5.2. Rising use of seaweed extract combinations with micronutrients for enhanced drought tolerance in cereals
  • 5.3. Adoption of drone and UAV based foliar application systems for precise non-microbial biostimulant delivery
  • 5.4. Regulatory harmonization efforts between US and EU to streamline registration of plant-derived biostimulants
  • 5.5. Integration of non-microbial biostimulants into seed coatings to boost early root development and uniform emergence
  • 5.6. Employing high throughput phenotyping to quantify efficacy of biostimulant treatments under abiotic stress conditions

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Non-microbial Biostimulants Market, by Product Type

  • 8.1. Introduction
  • 8.2. Amino Acids And Peptides
    • 8.2.1. Chelated Amino Solutions
    • 8.2.2. Peptides
  • 8.3. Humic Substances
    • 8.3.1. Fulvic Acid
    • 8.3.2. Potassium Humate
  • 8.4. Plant Extracts
    • 8.4.1. Botanical Extracts
    • 8.4.2. Plant Hormone Extracts
  • 8.5. Protein Hydrolysates
  • 8.6. Seaweed Extracts

9. Non-microbial Biostimulants Market, by Source

  • 9.1. Introduction
  • 9.2. Inorganic
  • 9.3. Organic

10. Non-microbial Biostimulants Market, by Crop Type

  • 10.1. Introduction
  • 10.2. Field Crops
    • 10.2.1. Cereals
    • 10.2.2. Oilseeds
    • 10.2.3. Pulses
  • 10.3. Fruits & Vegetables
    • 10.3.1. Berries
    • 10.3.2. Lettuce
    • 10.3.3. Tomatoes
  • 10.4. Ornamentals
    • 10.4.1. Hibiscus
    • 10.4.2. Orchids
    • 10.4.3. Roses
    • 10.4.4. Tulips
  • 10.5. Turf Grass
    • 10.5.1. Bermudagrass
    • 10.5.2. Kentucky Bluegrass

11. Non-microbial Biostimulants Market, by Form

  • 11.1. Introduction
  • 11.2. Liquid
    • 11.2.1. Concentrate
    • 11.2.2. Ready To Use
  • 11.3. Powder
    • 11.3.1. Granular
    • 11.3.2. Soluble Powder

12. Non-microbial Biostimulants Market, by Application Method

  • 12.1. Introduction
  • 12.2. Foliar Spray
    • 12.2.1. Drone Application
    • 12.2.2. Manual Application
  • 12.3. Seed Treatment
    • 12.3.1. Coating
    • 12.3.2. Priming
  • 12.4. Soil Treatment
    • 12.4.1. Drip Irrigation
    • 12.4.2. Fertigation

13. Non-microbial Biostimulants Market, by End User

  • 13.1. Introduction
  • 13.2. Commercial User
  • 13.3. Individual User

14. Non-microbial Biostimulants Market, by Distribution Channel

  • 14.1. Introduction
  • 14.2. Offline
  • 14.3. Online
    • 14.3.1. Company Websites
    • 14.3.2. Third Party Marketplaces

15. Americas Non-microbial Biostimulants Market

  • 15.1. Introduction
  • 15.2. United States
  • 15.3. Canada
  • 15.4. Mexico
  • 15.5. Brazil
  • 15.6. Argentina

16. Europe, Middle East & Africa Non-microbial Biostimulants Market

  • 16.1. Introduction
  • 16.2. United Kingdom
  • 16.3. Germany
  • 16.4. France
  • 16.5. Russia
  • 16.6. Italy
  • 16.7. Spain
  • 16.8. United Arab Emirates
  • 16.9. Saudi Arabia
  • 16.10. South Africa
  • 16.11. Denmark
  • 16.12. Netherlands
  • 16.13. Qatar
  • 16.14. Finland
  • 16.15. Sweden
  • 16.16. Nigeria
  • 16.17. Egypt
  • 16.18. Turkey
  • 16.19. Israel
  • 16.20. Norway
  • 16.21. Poland
  • 16.22. Switzerland

17. Asia-Pacific Non-microbial Biostimulants Market

  • 17.1. Introduction
  • 17.2. China
  • 17.3. India
  • 17.4. Japan
  • 17.5. Australia
  • 17.6. South Korea
  • 17.7. Indonesia
  • 17.8. Thailand
  • 17.9. Philippines
  • 17.10. Malaysia
  • 17.11. Singapore
  • 17.12. Vietnam
  • 17.13. Taiwan

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. BASF SE
    • 18.3.2. Syngenta AG
    • 18.3.3. Agricen
    • 18.3.4. Agrinos Inc.
    • 18.3.5. AgroLiquid
    • 18.3.6. Arysta LifeScience Corporation
    • 18.3.7. Bio Huma Netics, Inc.
    • 18.3.8. Bioiberica S.A.
    • 18.3.9. Biolchim S.p.A.
    • 18.3.10. Biostadt India Limited
    • 18.3.11. Corteva, Inc.
    • 18.3.12. FMC Corporation
    • 18.3.13. Haifa Group
    • 18.3.14. Helena Agri-Enterprises LLC
    • 18.3.15. Hello Nature Worldwide
    • 18.3.16. Isagro S.p.A.
    • 18.3.17. Koppert Biological Systems
    • 18.3.18. L.Gobbi Srl
    • 18.3.19. Lallemand Inc.
    • 18.3.20. Novozymes A/S
    • 18.3.21. Rovensa Next
    • 18.3.22. Seipasa
    • 18.3.23. UPL Limited

19. ResearchAI

20. ResearchStatistics

21. ResearchContacts

22. ResearchArticles

23. Appendix

LIST OF FIGURES

  • FIGURE 1. NON-MICROBIAL BIOSTIMULANTS MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 16. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 18. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 22. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. ASIA-PACIFIC NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 26. ASIA-PACIFIC NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 27. NON-MICROBIAL BIOSTIMULANTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. NON-MICROBIAL BIOSTIMULANTS MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 29. NON-MICROBIAL BIOSTIMULANTS MARKET: RESEARCHAI
  • FIGURE 30. NON-MICROBIAL BIOSTIMULANTS MARKET: RESEARCHSTATISTICS
  • FIGURE 31. NON-MICROBIAL BIOSTIMULANTS MARKET: RESEARCHCONTACTS
  • FIGURE 32. NON-MICROBIAL BIOSTIMULANTS MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. NON-MICROBIAL BIOSTIMULANTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CHELATED AMINO SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CHELATED AMINO SOLUTIONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FULVIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FULVIC ACID, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POTASSIUM HUMATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POTASSIUM HUMATE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY BOTANICAL EXTRACTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY BOTANICAL EXTRACTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT HORMONE EXTRACTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT HORMONE EXTRACTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PROTEIN HYDROLYSATES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEAWEED EXTRACTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEAWEED EXTRACTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY INORGANIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY INORGANIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORGANIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORGANIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CEREALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CEREALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY OILSEEDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY OILSEEDS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PULSES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PULSES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY BERRIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY BERRIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LETTUCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LETTUCE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TOMATOES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TOMATOES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HIBISCUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HIBISCUS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORCHIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORCHIDS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ROSES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ROSES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TULIPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TULIPS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY BERMUDAGRASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY BERMUDAGRASS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY KENTUCKY BLUEGRASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY KENTUCKY BLUEGRASS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CONCENTRATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CONCENTRATE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY READY TO USE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY READY TO USE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY GRANULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY GRANULAR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 101. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOLUBLE POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOLUBLE POWDER, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 103. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, 2025-2030 (USD MILLION)
  • TABLE 105. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 107. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 109. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DRONE APPLICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DRONE APPLICATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 111. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY MANUAL APPLICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY MANUAL APPLICATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 113. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, 2025-2030 (USD MILLION)
  • TABLE 115. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 117. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COATING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COATING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 119. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRIMING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRIMING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 121. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, 2025-2030 (USD MILLION)
  • TABLE 123. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 125. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DRIP IRRIGATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DRIP IRRIGATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 127. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FERTIGATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FERTIGATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 129. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2025-2030 (USD MILLION)
  • TABLE 131. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 133. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COMMERCIAL USER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COMMERCIAL USER, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 135. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY INDIVIDUAL USER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY INDIVIDUAL USER, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 137. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 139. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 141. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 143. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 145. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY THIRD PARTY MARKETPLACES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY THIRD PARTY MARKETPLACES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 147. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
  • TABLE 149. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 151. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, 2025-2030 (USD MILLION)
  • TABLE 153. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2025-2030 (USD MILLION)
  • TABLE 155. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, 2025-2030 (USD MILLION)
  • TABLE 157. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 159. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
  • TABLE 161. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, 2025-2030 (USD MILLION)
  • TABLE 163. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, 2025-2030 (USD MILLION)
  • TABLE 165. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, 2025-2030 (USD MILLION)
  • TABLE 167. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, 2025-2030 (USD MILLION)
  • TABLE 169. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
  • TABLE 171. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
  • TABLE 173. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, 2025-2030 (USD MILLION)
  • TABLE 175. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 177. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, 2025-2030 (USD MILLION)
  • TABLE 179. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, 2025-2030 (USD MILLION)
  • TABLE 181. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2025-2030 (USD MILLION)
  • TABLE 183. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 185. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 187. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
  • TABLE 189. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 191. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 193. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, 2018-2024 (USD MILLION)
  • TABLE 194. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, 2025-2030 (USD MILLION)
  • TABLE 195. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2024 (USD MILLION)
  • TABLE 196. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2025-2030 (USD MILLION)
  • TABLE 197. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, 2018-2024 (USD MILLION)
  • TABLE 198. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, 2025-2030 (USD MILLION)
  • TABLE 199. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 200. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 201. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
  • TABLE 203. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, 2018-2024 (USD MILLION)
  • TABLE 204. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, 2025-2030 (USD MILLION)
  • TABLE 205. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 206. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, 2025-2030 (USD MILLION)
  • TABLE 207. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, 2018-2024 (USD MILLION)
  • TABLE 208. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, 2025-2030 (USD MILLION)
  • TABLE 209. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, 2018-2024 (USD MILLION)
  • TABLE 210. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, 2025-2030 (USD MILLION)
  • TABLE 211. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 212. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
  • TABLE 213. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 214. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
  • TABLE 215. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
  • TABLE 216. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, 2025-2030 (USD MILLION)
  • TABLE 217. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 218. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 219. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, 2018-2024 (USD MILLION)
  • TABLE 220. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, 2025-2030 (USD MILLION)
  • TABLE 221. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 222. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, 2025-2030 (USD MILLION)
  • TABLE 223. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 224. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2025-2030 (USD MILLION)
  • TABLE 225. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 227. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 228. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 229. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 230. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
  • TABLE 231. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 232. UNITED STATES NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 233. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 235. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, 2018-2024 (USD MILLION)
  • TABLE 236. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, 2025-2030 (USD MILLION)
  • TABLE 237. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2024 (USD MILLION)
  • TABLE 238. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2025-2030 (USD MILLION)
  • TABLE 239. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, 2018-2024 (USD MILLION)
  • TABLE 240. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, 2025-2030 (USD MILLION)
  • TABLE 241. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 242. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 243. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
  • TABLE 245. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, 2018-2024 (USD MILLION)
  • TABLE 246. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, 2025-2030 (USD MILLION)
  • TABLE 247. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 248. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, 2025-2030 (USD MILLION)
  • TABLE 249. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, 2018-2024 (USD MILLION)
  • TABLE 250. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, 2025-2030 (USD MILLION)
  • TABLE 251. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, 2018-2024 (USD MILLION)
  • TABLE 252. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, 2025-2030 (USD MILLION)
  • TABLE 253. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 254. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
  • TABLE 255. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 256. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
  • TABLE 257. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
  • TABLE 258. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, 2025-2030 (USD MILLION)
  • TABLE 259. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 260. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 261. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, 2018-2024 (USD MILLION)
  • TABLE 262. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, 2025-2030 (USD MILLION)
  • TABLE 263. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 264. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, 2025-2030 (USD MILLION)
  • TABLE 265. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 266. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2025-2030 (USD MILLION)
  • TABLE 267. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 269. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 270. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 271. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 272. CANADA NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
  • TABLE 273. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 275. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, 2018-2024 (USD MILLION)
  • TABLE 276. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, 2025-2030 (USD MILLION)
  • TABLE 277. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2018-2024 (USD MILLION)
  • TABLE 278. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY HUMIC SUBSTANCES, 2025-2030 (USD MILLION)
  • TABLE 279. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, 2018-2024 (USD MILLION)
  • TABLE 280. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PLANT EXTRACTS, 2025-2030 (USD MILLION)
  • TABLE 281. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 282. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
  • TABLE 283. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
  • TABLE 285. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, 2018-2024 (USD MILLION)
  • TABLE 286. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FIELD CROPS, 2025-2030 (USD MILLION)
  • TABLE 287. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 288. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FRUITS & VEGETABLES, 2025-2030 (USD MILLION)
  • TABLE 289. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, 2018-2024 (USD MILLION)
  • TABLE 290. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ORNAMENTALS, 2025-2030 (USD MILLION)
  • TABLE 291. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, 2018-2024 (USD MILLION)
  • TABLE 292. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY TURF GRASS, 2025-2030 (USD MILLION)
  • TABLE 293. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 294. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
  • TABLE 295. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 296. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
  • TABLE 297. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, 2018-2024 (USD MILLION)
  • TABLE 298. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY POWDER, 2025-2030 (USD MILLION)
  • TABLE 299. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 300. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
  • TABLE 301. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, 2018-2024 (USD MILLION)
  • TABLE 302. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY FOLIAR SPRAY, 2025-2030 (USD MILLION)
  • TABLE 303. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 304. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SEED TREATMENT, 2025-2030 (USD MILLION)
  • TABLE 305. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 306. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY SOIL TREATMENT, 2025-2030 (USD MILLION)
  • TABLE 307. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 309. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 310. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 311. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 312. MEXICO NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
  • TABLE 313. BRAZIL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. BRAZIL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 315. BRAZIL NON-MICROBIAL BIOSTIMULANTS MARKET SIZE, BY AMINO ACIDS AND PEPTIDES, 2018-2024 (USD MILLION)
  • TABLE 316. BRAZI